Horizon Therapeutics Public Limited Co (fka HZNP)

[surf1944]

7:32AM Horizon Pharma announces receipt of additional U.S. Patent Allowance for DUEXIS (HZNP) 2.26 : Co announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application Serial No. 13/620,150 entitled "Stable Compositions of Famotidine and Ibuprofen" with claims that cover DUEXIS (ibuprofen and famotidine) tablets. DUEXIS is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers.